|
þ
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |
| For the period ended April 30, 2005 | ||
| or | ||
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |
| For the transition period from to | ||
|
Massachusetts
|
04-2454372 | |
|
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
|
|
8 Centennial Drive Peabody, Massachusetts (Address of principal executive offices) |
01960 (Zip Code) |
|
2
| Item 1. | Financial Statements |
| April 30, | July 31, | |||||||||
| 2005 | 2004 | |||||||||
| ASSETS | ||||||||||
|
Current assets:
|
||||||||||
|
Cash and cash equivalents
|
$ | 215,449 | $ | 149,549 | ||||||
|
Marketable securities, at fair value
|
15,589 | 27,088 | ||||||||
|
Accounts and notes receivable, net of allowance for doubtful
accounts of $2,569 at April 30, 2005 and $2,493 at
July 31, 2004
|
51,859 | 55,498 | ||||||||
|
Inventories
|
69,068 | 65,952 | ||||||||
|
Costs related to deferred revenue
|
13,905 | 12,723 | ||||||||
|
Refundable and deferred income taxes
|
15,904 | 10,861 | ||||||||
|
Other current assets
|
7,577 | 6,450 | ||||||||
|
Total current assets
|
389,351 | 328,121 | ||||||||
|
Property, plant and equipment, net
|
90,220 | 91,077 | ||||||||
|
Investments in and advances to affiliated companies
|
1,448 | 10,967 | ||||||||
|
Capitalized software, net
|
12,233 | 9,502 | ||||||||
|
Goodwill
|
746 | 1,565 | ||||||||
|
Intangible assets, net
|
5,568 | 9,223 | ||||||||
|
Costs related to deferred revenue
|
219 | 219 | ||||||||
|
Other assets
|
4,972 | 1,397 | ||||||||
|
Total Assets
|
$ | 504,757 | $ | 452,071 | ||||||
| LIABILITIES AND STOCKHOLDERS EQUITY | ||||||||||
|
Current liabilities:
|
||||||||||
|
Notes payable
|
$ | 42 | $ | 785 | ||||||
|
Obligations under capital leases
|
137 | 177 | ||||||||
|
Accounts payable, trade
|
22,460 | 21,707 | ||||||||
|
Accrued liabilities
|
22,034 | 21,380 | ||||||||
|
Deferred revenue
|
28,985 | 26,281 | ||||||||
|
Advance payments
|
15,831 | 6,125 | ||||||||
|
Accrued income taxes
|
17,069 | 5,791 | ||||||||
|
Total current liabilities
|
106,558 | 82,246 | ||||||||
|
Long-term liabilities:
|
||||||||||
|
Obligations under capital leases
|
70 | 155 | ||||||||
|
Deferred revenue
|
1,296 | 1,459 | ||||||||
|
Deferred income taxes
|
1,487 | 810 | ||||||||
|
Total long-term liabilities
|
2,853 | 2,424 | ||||||||
|
Commitments and guarantees (Note 14)
|
||||||||||
|
Stockholders equity:
|
||||||||||
|
Common stock, $.05 par value
|
715 | 713 | ||||||||
|
Capital in excess of par value
|
49,527 | 47,257 | ||||||||
|
Retained earnings
|
345,312 | 324,025 | ||||||||
|
Accumulated other comprehensive income
|
6,019 | 2,141 | ||||||||
|
Unearned compensation
|
(6,227 | ) | (6,735 | ) | ||||||
|
Total stockholders equity
|
395,346 | 367,401 | ||||||||
|
Total Liabilities and Stockholders Equity
|
$ | 504,757 | $ | 452,071 | ||||||
3
| Three Months Ended | Nine Months Ended | |||||||||||||||||
| April 30, | April 30, | |||||||||||||||||
| 2005 | 2004 | 2005 | 2004 | |||||||||||||||
|
Net revenue:
|
||||||||||||||||||
|
Product
|
$ | 87,230 | $ | 82,573 | $ | 242,517 | $ | 232,146 | ||||||||||
|
Engineering
|
5,221 | 4,733 | 13,630 | 15,329 | ||||||||||||||
|
Other
|
1,715 | 1,666 | 6,426 | 5,847 | ||||||||||||||
|
Total net revenue
|
94,166 | 88,972 | 262,573 | 253,322 | ||||||||||||||
|
Cost of sales:
|
||||||||||||||||||
|
Product
|
53,111 | 50,046 | 147,744 | 138,554 | ||||||||||||||
|
Engineering
|
3,817 | 3,503 | 11,359 | 8,439 | ||||||||||||||
|
Other
|
1,256 | 1,156 | 3,974 | 3,505 | ||||||||||||||
|
Total cost of sales
|
58,184 | 54,705 | 163,077 | 150,498 | ||||||||||||||
|
Gross margin
|
35,982 | 34,267 | 99,496 | 102,824 | ||||||||||||||
|
Operating expenses:
|
||||||||||||||||||
|
Research and product development
|
15,219 | 14,084 | 44,428 | 43,869 | ||||||||||||||
|
Selling and marketing
|
9,365 | 9,552 | 28,093 | 27,371 | ||||||||||||||
|
General and administrative
|
11,034 | 10,333 | 31,689 | 28,887 | ||||||||||||||
|
Asset impairment charges
|
5,587 | | 6,534 | | ||||||||||||||
|
Total operating expenses
|
41,205 | 33,969 | 110,744 | 100,127 | ||||||||||||||
|
Income (loss) from operations
|
(5,223 | ) | 298 | (11,248 | ) | 2,697 | ||||||||||||
|
Other (income) expense:
|
||||||||||||||||||
|
Interest income
|
(1,484 | ) | (743 | ) | (3,369 | ) | (2,829 | ) | ||||||||||
|
Interest expense
|
5 | 61 | 26 | 253 | ||||||||||||||
|
Equity gain in unconsolidated affiliates
|
(966 | ) | (847 | ) | (727 | ) | (848 | ) | ||||||||||
|
Gain on sale of marketable securities
|
(43,829 | ) | | (43,829 | ) | | ||||||||||||
|
Other
|
313 | 322 | (267 | ) | 317 | |||||||||||||
|
Total other (income) expense
|
(45,961 | ) | (1,207 | ) | (48,166 | ) | (3,107 | ) | ||||||||||
|
Income before income taxes
|
40,738 | 1,505 | 36,918 | 5,804 | ||||||||||||||
|
Provision for income taxes
|
12,618 | 365 | 12,343 | 1,354 | ||||||||||||||
|
Net income
|
$ | 28,120 | $ | 1,140 | $ | 24,575 | $ | 4,450 | ||||||||||
|
Net income per common share:
|
||||||||||||||||||
|
Basic
|
$ | 2.07 | $ | 0.08 | $ | 1.81 | $ | 0.33 | ||||||||||
|
Diluted
|
2.07 | 0.08 | 1.81 | 0.33 | ||||||||||||||
|
Weighted average shares outstanding:
|
||||||||||||||||||
|
Basic
|
13,573 | 13,492 | 13,546 | 13,428 | ||||||||||||||
|
Diluted
|
13,614 | 13,508 | 13,588 | 13,506 | ||||||||||||||
4
| Nine Months Ended | |||||||||||
| April 30, | |||||||||||
| 2005 | 2004 | ||||||||||
|
OPERATING ACTIVITIES:
|
|||||||||||
|
Net income
|
$ | 24,575 | $ | 4,450 | |||||||
|
Adjustments to reconcile net income to net cash provided by
operating activities:
|
|||||||||||
|
Deferred income taxes
|
(1,864 | ) | 745 | ||||||||
|
Depreciation and amortization
|
15,374 | 15,554 | |||||||||
|
Allowance for doubtful accounts
|
294 | 2 | |||||||||
|
Asset impairment charges
|
6,534 | | |||||||||
|
Gain on sale of property, plant, and equipment
|
(13 | ) | (26 | ) | |||||||
|
Equity gain in unconsolidated affiliates
|
(727 | ) | (848 | ) | |||||||
|
Equity loss in unconsolidated affiliate classified as research
and product development expense
|
759 | 2,564 | |||||||||
|
Gain on sale of Cedara investment
|
(43,829 | ) | | ||||||||
|
Non-cash compensation expense from stock grants
|
1,532 | 1,147 | |||||||||
|
Net changes in operating assets and liabilities (Note 11)
|
19,657 | 621 | |||||||||
|
NET CASH PROVIDED BY OPERATING ACTIVITIES
|
22,292 | 24,209 | |||||||||
|
INVESTING ACTIVITIES:
|
|||||||||||
|
Investments in and advances to affiliated companies
|
(2,260 | ) | (19 | ) | |||||||
|
Acquisition of businesses, net of cash acquired
|
| (141 | ) | ||||||||
|
Acquisition of assets
|
| (1,750 | ) | ||||||||
|
Proceeds from the sale of Cedara investment
|
50,752 | | |||||||||
|
Additions to property, plant and equipment
|
(8,598 | ) | (17,948 | ) | |||||||
|
Capitalized software
|
(4,202 | ) | (2,851 | ) | |||||||
|
Proceeds from sale of property, plant and equipment
|
90 | 171 | |||||||||
|
Maturities of marketable securities
|
11,060 | 8,775 | |||||||||
|
NET CASH PROVIDED BY (USED FOR) INVESTING ACTIVITIES
|
46,842 | (13,763 | ) | ||||||||
|
FINANCING ACTIVITIES:
|
|||||||||||
|
Payments on debt and capital lease obligations
|
(743 | ) | (5,100 | ) | |||||||
|
Issuances of stock pursuant to exercise of stock options and
employee stock purchase plan
|
1,159 | 3,111 | |||||||||
|
Dividends paid to shareholders
|
(3,288 | ) | (3,250 | ) | |||||||
|
NET CASH USED FOR FINANCING ACTIVITIES
|
(2,872 | ) | (5,239 | ) | |||||||
|
EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS
|
(362 | ) | 291 | ||||||||
|
NET INCREASE IN CASH AND CASH EQUIVALENTS
|
65,900 | 5,498 | |||||||||
|
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD
|
149,549 | 136,806 | |||||||||
|
CASH AND CASH EQUIVALENTS, END OF PERIOD
|
$ | 215,449 | $ | 142,304 | |||||||
5
| 1. | Basis of presentation: |
| 2. | Stock-based compensation: |
| Three Months Ended | Nine Months Ended | ||||||||||||||||
| April 30, | April 30, | ||||||||||||||||
| 2005 | 2004 | 2005 | 2004 | ||||||||||||||
|
Net income, as reported
|
$ | 28,120 | $ | 1,140 | $ | 24,575 | $ | 4,450 | |||||||||
|
Add: Stock-based employee compensation expense included in
reported net income, net of related tax effects
|
237 | 207 | 871 | 693 | |||||||||||||
|
Deduct: Stock-based employee compensation expense determined
under fair value based method for all awards, net of related tax
effects
|
(861 | ) | (799 | ) | (2,962 | ) | (2,696 | ) | |||||||||
|
Pro forma net income
|
$ | 27,496 | $ | 548 | $ | 22,484 | $ | 2,447 | |||||||||
|
Earnings per share:
|
|||||||||||||||||
|
Basic as reported
|
$ | 2.07 | $ | 0.08 | $ | 1.81 | $ | 0.33 | |||||||||
|
Basic pro forma
|
2.03 | 0.04 | 1.66 | 0.18 | |||||||||||||
|
Diluted as reported
|
2.07 | 0.08 | 1.81 | 0.33 | |||||||||||||
|
Diluted pro forma
|
2.02 | 0.04 | 1.65 | 0.18 | |||||||||||||
6
| 3. | Balance sheet information: |
| April 30, | July 31, | ||||||||
| 2005 | 2004 | ||||||||
|
Inventories:
|
|||||||||
|
Raw materials
|
$ | 40,375 | $ | 36,246 | |||||
|
Work-in-process
|
15,022 | 12,400 | |||||||
|
Finished goods
|
13,671 | 17,306 | |||||||
| $ | 69,068 | $ | 65,952 | ||||||
|
Accrued liabilities:
|
|||||||||
|
Accrued employee compensation and benefits
|
$ | 12,573 | $ | 11,247 | |||||
|
Accrued warranty
|
5,110 | 5,039 | |||||||
|
Other
|
4,351 | 5,094 | |||||||
| $ | 22,034 | $ | 21,380 | ||||||